MENU
BIVI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioVie (BIVI) Ownership - Who owns BioVie?
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers... Show more
Profile
Industry
N/A
Address
680 W Nye Lane
Phone
+1 775 888-3162
Employees
13
Web
https://www.bioviepharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.63M
P/E Ratio
N/A
Total Cash
24.41M
Projected Growth
N/A
Total Debt
382.03K
Revenue
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
1.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BIVI
Capitalization
14.6M
P/E Ratio
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash
24.4M
Total Cash/Share
1.32
Total Debt
382K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
23.9M
P/B Ratio
0.61
Cash Flow
N/A
Earnings
-3.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.46K
Current Ratio
16.94
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-22.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-108.21
Shares Held By Institutions
2.1M
Shares Outstanding - Current
18.5M
Total Liabilities
1.77M
Total Volume MTD
N/A
Value
1
Gain YTD
-60.350
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
680 W Nye Lane
Phone
+1 775 888-3162
Employees
13
Web
https://www.bioviepharma.com